Answers are grounded in this paper and cite their sources.
We describe herein a scalable catalytic asymmetric hydrogenation process for the multikilogram-scale production of a β 2 -amino acid. A short and efficient synthesis of the starting unsaturated N -Boc-protected β 2 -enamide was developed followed by extensive catalysis screening and optimization studies that identified a simple Ru-BINAP catalyst system to directly afford the ( S ) product in high enantiomeric excess and yield. The final process enabled the multikilogram production in >99% ee, to be used as a key component for one of our clinical candidates.
No takes yet. Share an insight, caveat, or question.
Remarchuk et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: